QC
IONS icon

Quent Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Quent Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.32K Buy
105
+6
+6% +$452 ﹤0.01% 1283
2026
Q1 		$7.43K Hold
99
– – ﹤0.01% 1212
2025
Q4 		$7.83K Buy
99
+1
+1% +$75 ﹤0.01% 1200
2025
Q3 		$6.41K Buy
+98
New +$4.79K ﹤0.01% 1101
2025
Q2 		– Sell
-53
Closed -$1.6K – 758
2025
Q1 		$1.6K Sell
53
-21
-28% -$688 ﹤0.01% 1163
2024
Q4 		$2.59K Hold
74
– – ﹤0.01% 1136
2024
Q3 		$2.96K Hold
74
– – ﹤0.01% 1185
2024
Q2 		$3.53K Buy
74
+19
+35% +$779 ﹤0.01% 1144
2024
Q1 		$2.38K Buy
55
+34
+162% +$1.62K ﹤0.01% 1208
2023
Q4 		$1.06K Buy
+21
New +$1.01K ﹤0.01% 1256

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Quent Capital's IONS Position: Q2 2026 in Review

Quent Capital increased its Ionis Pharmaceuticals (IONS) stake by 6.1% in Q2 2026, buying an estimated $452 and bringing the position to 105 shares worth $8.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1283.

Quent Capital first reported a position in IONS in Q4 2023 and has held it in 10 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Quent Capital held 105 shares of Ionis Pharmaceuticals worth $8.32K as of Q2 2026.
  • Quent Capital bought 6 Ionis Pharmaceuticals shares in Q2 2026, an estimated $452.
  • Ionis Pharmaceuticals made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1283 holding.
  • Quent Capital first reported a position in Ionis Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.